Additional file 1: of ASC-J9® increases the bladder cancer chemotherapy efficacy via altering the androgen receptor (AR) and NF-κB survival signals

Figure S1. The illustration of xenografts and timeline of treatment regimen with Cisplatin (Cis) and ASC-J9® (ASC). Red arrows = ASC, black arrows = Cis. (PDF 84 kb)